Article révisé par les pairs
Titre:
  • Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials
Auteur:Solinas, Cinzia; Sotiriou, Christos; Willard-Gallo, Karen; Ignatiadis, Michail; Ceppi, Marcello; Lambertini, Matteo; Scartozzi, Mario; Buisseret, Laurence; Garaud, Soizic; Fumagalli, Debora; de Azambuja, Evandro; Salgado, Roberto
Informations sur la publication:Cancer treatment reviews, 57, page (8-15)
Statut de publication:Publié, 2017-06
Sujet CREF:Cancérologie
Imagerie médicale, radiologie, tomographie
Mots-clés:HER2-postive breast cancer
Lapatinib
Neoadjuvant treatment
Pathologic complete response
Trastuzumab
Tumor-infiltrating lymphocytes
MeSH keywords:Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy -- enzymology -- immunology -- pathology
Chemotherapy, Adjuvant
Female
Humans
Lapatinib
Lymphocytes, Tumor-Infiltrating -- drug effects -- immunology -- pathology
Neoadjuvant Therapy
Quinazolines -- administration & dosage
Randomized Controlled Trials as Topic
Receptor, ErbB-2 -- antagonists & inhibitors -- biosynthesis
Trastuzumab -- administration & dosage
Note générale:SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:0305-7372
info:doi/10.1016/j.ctrv.2017.04.005
info:pii/S0305737217300634
info:scp/85019440425
info:pmid/28525810

Documents en relation

DI-fusion